You are here
Targeted Prodrug Therapy of Liver Cancers
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43CA105617-01
Agency Tracking Number: CA105617
Amount:
$100,000.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
ACCLAIM BIOTECHNOLOGY
3520 PLUMB ST
HOUSTON, TX
77005
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: JOHN Chan
Phone: (713) 792-3214
Email: CHANYHJOHN@HOTMAIL.COM
Phone: (713) 792-3214
Email: CHANYHJOHN@HOTMAIL.COM
Business Contact
Phone: (713) 792-3256
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Hepatocellular carcinoma (HCC) and colorectal cancer (CRC) are among the most common and deadly malignancy worldwide. CRC is the second leading cause of cancer-related death in the USA, mostly due to metastases to the
* Information listed above is at the time of submission. *